Year: 2022
Type: review
Source: Nature reviews. Cancer
Institutions: Brigham and Women's Hospital, Howard Hughes Medical Institute, Harvard University, Koch Institute for Integrative Cancer Research At MIT, Massachusetts Institute of Technology, National University of Singapore, A*STAR-NUS Clinical Imaging Research Centre, Frederick National Laboratory for Cancer Research, Universitätsklinikum Aachen
Language: English
Subfield: Biomedical Engineering
Field: Engineering
Domain: Physical Sciences
Open Access status: bronze
Funders: Howard Hughes Medical Institute, U.S. Department of Health and Human Services, European Commission, Deutsche Forschungsgemeinschaft, Bundesministerium für Bildung und Forschung, National Institutes of Health, Medical Research Council, National Medical Research Council, European Regional Development Fund, National Cancer Institute, H2020 European Research Council, FP7 Ideas: European Research Council
Awards: G1029758679, G1046779516, G1087064186, G117455193, G1234541941, Macro-Nanomedicine to Treat Metastatic Cancer, G2844955175, Companion Nanodiagnostics for Quantifying EPR and Stratifying Patients to Targeted Nanotherapies, G402796064, G4689185066, G4784756811, Penetration-promoting and Imageable Polymeric Micelles as a Platform Technology for Individualized and Improved Tumor-targeted Drug Delivery, G6252953675, G6687727641, Neoadjuvant Nanomedicines for vascular Normalization, G7839592, G798012157, GRK 2375: TumorTargeted Drug Delivery
OpenAlex ID: W4290643250